The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Marine Polymer Technologies sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Marine Polymer Technologies Inc (MPT) is a medical equipment company that is involved in the research, development, and commercialization of innovative technologies aimed at enhancing patient hemostasis and wound healing. The company’s product portfolio includes Syvek, a vascular catheterization device; Talymed, a wound healing device for diabetic foot ulcers, venous leg ulcers, and pressure wounds; and MRDH, for severe bleeding. The company uses its proprietary technology, Poly-N-acetyl glucosamine for bleeding control. It markets its products in the US, Europe, and Korea. MPT is headquartered in Tewksbury, Massachusetts, the US.
The key metrics of Marine Polymer Technologies related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Marine Polymer Technologies is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Marine Polymer Technologies.
For a detailed understanding of the performance of Marine Polymer Technologies, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
